TP53 and colorectal carcinoma: Mutations of APC, TP53 and KRAS have been proposed as a genetic model, which drives the transition from healthy colonic epithelia to CRC through increasingly dysplastic adenoma, and these mutations lie on alternate pathways of CRC development.